Beta-Blocker Therapy for Congestive Heart Failure

Introduction to Beta-Blocker Therapy

• The American College of Cardiology Foundation/American Heart Association (ACCF/AHA) guidelines provide a Class I recommendation (Level of Evidence: A) for using one of the three beta-blockers proven to reduce mortality: bisoprolol, carvedilol, and metoprolol succinate (extended-release) 2
• Three specific beta-blockers are recommended for congestive heart failure: bisoprolol, carvedilol, and metoprolol succinate (extended-release), which have demonstrated mortality benefits in clinical trials and are considered first-line therapy for heart failure with reduced ejection fraction (HFrEF) 1, 2

Recommended Beta-Blockers and Their Properties

• Bisoprolol selectively blocks beta-1 receptors 2
• Metoprolol succinate selectively blocks beta-1 receptors 2
• The following beta-blockers have demonstrated mortality benefits and are recommended for use in HFrEF:

1, 3

Patient Selection and Timing of Beta-Blocker Initiation

• All stable patients with HFrEF should receive a beta-blocker unless contraindicated 2
• Initiate beta-blocker therapy as soon as HFrEF is diagnosed, even when symptoms are mild 2
• Patients need not be on maximum ACE inhibitor doses before starting beta-blockers 2

Titration and Monitoring of Beta-Blocker Therapy

• Double the dose at 2-week intervals if tolerated 1, 3
• Check heart rate, blood pressure, clinical status, and signs of congestion during titration 1
• Aim for the target dose or highest tolerated dose 1, 3

Common Mistakes in Beta-Blocker Therapy

• Withholding beta-blockers due to mild symptoms is a mistake; even patients with minimal symptoms benefit from beta-blockers to prevent disease progression 2
• Stopping beta-blockers abruptly is a mistake; never stop beta-blockers suddenly due to risk of rebound ischemia and arrhythmias 1
• Not using beta-blockers with diuretics is a mistake; in patients with fluid retention, always use diuretics with beta-blockers to prevent exacerbation 2
• Delaying beta-blocker initiation until ACE inhibitor is at target dose is a mistake; adding a beta-blocker to a low-dose ACE inhibitor provides greater benefits than increasing the ACE inhibitor dose 2
• Using non-evidence-based beta-blockers is a mistake; only use bisoprolol, carvedilol, or metoprolol succinate for heart failure 1, 2

Special Considerations for Beta-Blocker Therapy

• Seek specialist advice before initiating beta-blocker therapy in patients with severe (NYHA class IV) CHF 1
• Wait at least 4 weeks after hospitalization for worsening CHF before initiating beta-blocker therapy 1
• Use caution if heart rate <60/min or heart block present 1
• Address persistent signs of congestion before initiating beta-blocker therapy 1